Reynders Mc Veigh Capital Management, LLC Gilead Sciences, Inc. Transaction History

Reynders Mc Veigh Capital Management, LLC

$1.76 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $21,434 - $24,449	-282 Reduced 7.13%	3,673 $283,000
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $27,676 - $31,532	358 Added 9.95%	3,955 $328,000
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $10,656 - $15,299	-171 Reduced 4.54%	3,597 $309,000
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $10,181 - $11,629	171 Added 4.75%	3,768 $232,000
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $207,618 - $233,840	3,597 New	3,597 $222,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $179,262 - $224,635	-3,095 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $41,782 - $47,424	-644 Reduced 17.22%	3,095 $225,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $43,592 - $47,031	644 Added 20.81%	3,739 $261,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $254,197 - $277,746	-4,005 Reduced 56.41%	3,095 $213,000
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $15,720 - $17,936	-262 Reduced 3.56%	7,100 $459,000
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $240,196 - $273,692	-4,240 Reduced 36.55%	7,362 $429,000
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $90,293 - $113,528	-1,454 Reduced 11.14%	11,602 $733,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $105,544 - $122,556	1,459 Added 12.58%	13,056 $1.01 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $5,887 - $7,540	-94 Reduced 0.8%	11,597 $867,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $63,160 - $69,474	-1,025 Reduced 8.06%	11,691 $760,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $625 - $690	-10 Reduced 0.08%	12,716 $806,000
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $62,364 - $69,935	-1,008 Reduced 7.34%	12,726 $860,000
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $315,526 - $353,472	-5,046 Reduced 26.87%	13,734 $893,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $1.11 Million - $1.44 Million	-18,277 Reduced 49.32%	18,780 $1.18 Million
Q3 2018 Nov 26, 2018	SELL	$71.28 - $78.92 $2.95 Million - $3.27 Million	-41,374 Reduced 52.75%	37,057 $2.86 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $175,240 - $204,411	2,701 Added 3.57%	78,431 $5.56 Million
Q1 2018 Jul 26, 2018	BUY	$72.84 - $88.8 $5.1 Million - $6.22 Million	70,021 Added 1226.5%	75,730 $5.71 Million
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $4.54 Million - $5.54 Million	-62,370 Reduced 91.61%	5,709 $75.7 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $1.41 Million - $1.65 Million	19,800 Added 41.01%	68,079 $0
Q3 2017 Nov 09, 2017	SELL	$72.11 - $85.47 $294,425 - $348,974	-4,083 Reduced 7.8%	48,279 $3.91 Million
Q2 2017 Aug 14, 2017	BUY	N/A	52,362	52,362 $3.71 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.

Account